Market capitalization | €9.40b |
Enterprise Value | €13.31b |
P/E (TTM) P/E ratio | 24.92 |
EV/FCF (TTM) EV/FCF | 19.74 |
EV/Sales (TTM) EV/Sales | 1.98 |
P/S ratio (TTM) P/S ratio | 1.40 |
P/B ratio (TTM) P/B ratio | 2.21 |
Dividend yield | 1.02% |
Last dividend (FY23) | €0.50 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
14 Analysts have issued a Eurofins Scientific forecast:
14 Analysts have issued a Eurofins Scientific forecast:
Jun '24 |
+/-
%
|
||
Revenue | 6,724 6,724 |
3%
3%
|
|
Gross Profit | 654 654 |
17%
17%
|
|
EBITDA | 1,337 1,337 |
13%
13%
|
EBIT (Operating Income) EBIT | 654 654 |
17%
17%
|
Net Profit | 380 380 |
16%
16%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg.
Head office | France |
CEO | Gilles Martin |
Employees | 61,798 |
Founded | 2012 |
Website | www.eurofins.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.